21 not yet recruiting, 16 completed, 12 recruiting, 4 active not recruiting. 32 Not applicable, 7 Phase 2, 6 Phase 1, 3 Phase 4.
Follow HIV (Human Immunodeficiency Virus): new trials by email Literature Review of HIV (Human Immunodeficiency Virus) trials Research Report on HIV (Human Immunodeficiency Virus)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluating a Clinical Decision Support Tool for Antiretroviral Therapy Optimization smART (Smart Antiretroviral Therapy Assistant), Traditional Prescribing resources - HIV (Human Immunodeficiency Virus), Clinical Decision Support System (CDSS) | Not applicable | Not yet recruiting | Keck School of Medicine of USC | 250 | 2028-09-01 | 2025-10-22 |
| Testing a Multi-Level Approach to Reduce Stigma for Women Living With HIV Labda Siku Moja, Total Facility Approach - HIV (Human Immunodeficiency Virus) | Not applicable | Not yet recruiting | RTI International | 680 | 2027-03-01 | 2026-10-19 |
| A Clinical Study of Ixazomib to Reactivate HIV and Reduce HIV Reservoir Size Ixazomib 4 mg, Placebo - HIV (Human Immunodeficiency Virus) | Phase 2 | Not yet recruiting | National Institute of Allergy and Infectious Diseases (NIAID) | 45 | 2026-11-23 | 2026-10-19 |
| A Clinical Study to Evaluate the Safety and Immunogenicity of a Higher Dose of the Study Vaccine, VIR-1388, in HCMV-seropositive Adult Participants Without HIV VIR-1388, Placebo - Cytomegalovirus (CMV), HIV (Human Immunodeficiency Virus) | Phase 1 | Not yet recruiting | National Institute of Allergy and Infectious Diseases (NIAID) | 12 | 2026-10-15 | 2026-09-03 |
| Feasibility Study Comparing One vs Two Probes for Thermal Ablation Among Cervical Cancer Screen Positive Women Living With HIV in C1001P-CS7 Zimbabwe Thermal ablation (TA) with 1 probe, Thermal ablation (TA) with 2 probes - HIV (Human Immunodeficiency Virus), HPV | Not applicable | Recruiting | Fred Hutchinson Cancer Center | 300 | 2026-10-15 | 2026-10-19 |
| Feasibility Study Comparing One vs Two Probes for TA Among Cervical Cancer Screen Positive WLWH in C1001P-CS5 Rwanda Thermal ablation (TA) with 1 probe, Thermal ablation (TA) with 2 probes - HIV (Human Immunodeficiency Virus), HPV | Not applicable | Recruiting | Fred Hutchinson Cancer Center | 300 | 2026-10-15 | 2026-10-19 |
| Feasibility Study Comparing One vs Two Probes for Thermal Ablation Among Cervical Cancer Screen Positive WLWH in C1001P-CS9 South Africa Thermal ablation (TA) with 1 probe, Thermal ablation (TA) with 2 probes - HIV (Human Immunodeficiency Virus), HPV | Not applicable | Recruiting | Fred Hutchinson Cancer Center | 200 | 2026-10-15 | 2026-10-20 |
| Feasibility Study Comparing Use of One Or Two Probes for Thermal Ablation Among Screen Positive Women Living With HIV in C1001P-CS2 Kenya Thermal ablation (TA) with 1 probe, Thermal ablation (TA) with 2 probes - HIV (Human Immunodeficiency Virus), HPV | Not applicable | Recruiting | Fred Hutchinson Cancer Center | 300 | 2026-10-12 | 2026-10-20 |
| Sleep Outcomes and Multidimensional Sleep Assessment - a Randomized Trial of Dolutegravir- vs Doravirine-based Antiretroviral Therapy in People Living With HIV Tenofovir disoproxil fumarate 300mg / Lamivudine 300mg / Doravirine 100mg, Tenofovir disoproxil fumarate 300mg / Lamivudine 300mg / Dolutegravir 50mg - HIV (Human Immunodeficiency Virus), Sleep | Phase 4 | Not yet recruiting | University of Witwatersrand, South Africa | 40 | 2026-10-05 | 2026-10-06 |
| Auricular Point Acupressure for Pain Auricular Point Acupressure, Sham Auricular Point Acupressure - HIV (Human Immunodeficiency Virus), Pain | Not applicable | Not yet recruiting | Dan Song | 30 | 2026-10-01 | 2026-10-01 |
| Vaginal Estradiol vs Moisturizer to Improve Postmenopausal Vaginal Aging Symptoms and the Microbiome in Women Living With HIV Vaginal estradiol tablets, Vaginal moisturizer - Menopausal Complaints, Vaginal Atrophy | Phase 4 | Not yet recruiting | Albert Einstein College of Medicine | 62 | 2026-09-01 | 2026-07-28 |
| PNF RCT to Decrease Alcohol Use and Increase HIV Prevention PNF - HIV norms, PNF - Alcohol use norms, PNF - HIV and alcohol use norms - HIV (Human Immunodeficiency Virus), Alcohol Misuse | Not applicable | Not yet recruiting | Vanderbilt University | 1350 | 2026-09-01 | 2026-07-28 |
| Multimorbidity and Polypharmacy in People With HIV vs. the General Population in the Basque Country No intervention - HIV (Human Immunodeficiency Virus) | Not yet recruiting | Biogipuzkoa Health Research Institute | 12546 | 2026-09-01 | 2026-06-12 | |
| Screening With Portable X-rays for Rapid Recognition of TB Mobile chest radiography for tuberculosis screening - Tuberculosis (TB), Tuberculosis Infection, Latent | Not applicable | Recruiting | Columbia University | 1000 | 2026-08-25 | 2026-10-02 |
| Stimulant and Polysubstance Use, Inflammation, and Sex Effects on Myocardial Disease in HIV HIV (Human Immunodeficiency Virus) | Enrolling by invitation | University of California, San Francisco | 400 | 2026-08-05 | 2026-08-11 | |
| Disease Evolution and Risk Factors of AIDS-related Prevalent Cancers HIV (Human Immunodeficiency Virus), AIDS | Not yet recruiting | Shenzhen Third People's Hospital | 1000 | 2026-07-01 | 2026-07-10 | |
| Assessing Performance of a Hepatitis C Emergency Department (HepC-EnD) Screening Tool: IT Integration Process for Electronic Health Record System Physician-Initiated Screening (Conventional Screening), FOCUS (Universal Screening), HepC-EnD (Targeted Screening) - Hepatitis C Virus (HCV), Hepatitis C Virus (HCV) Infection | Not yet recruiting | University of Florida | 6466 | 2026-07-01 | 2026-04-29 | |
| REINItiation of Antiretroviral Therapy Using Oral bicTegravir, emtrIcitAbine and Tenofovir alafenamidE Bictegravir, emtricitabine, and tenofovir alafenamide - HIV -1 Infection, HIV (Human Immunodeficiency Virus) | Phase 4 | Recruiting | CAN Community Health | 200 | 2026-06-17 | 2026-09-03 |
| Lipidomic and Multi-Omics Profiling of Fatty Liver Disease in People With and Without HIV MASLD, HIV (Human Immunodeficiency Virus) | Not yet recruiting | Yinzhong Shen | 120 | 2026-06-01 | 2026-06-11 | |
| A Clinical Study Evaluating the Safety, Tolerability, and Effect on HIV Reservoir of Ibalizumab Combined With Chidamide (a Histone Deacetylase Inhibitor) in People Living With HIV Ibalizumab Combined with Chidamide - HIV (Human Immunodeficiency Virus) | Phase 1 | Not yet recruiting | First Affiliated Hospital of Zhejiang University | 18 | 2026-06-01 | 2026-06-09 |
Showing 20 of 60. Sign in to see all of them.
Acquired Immunodeficiency Syndrome (60) · Uterine Cervical Dysplasia (4) · HIV Infections (3) · Sexually Transmitted Diseases (3) · Social Stigma (3) · Tuberculosis (3) · Anus Neoplasms (2) · Emergencies (2) · Hepatitis C (2) · Metabolic Syndrome (2) · Obesity (2) · Substance-Related Disorders (2) · Syphilis (2) · Uterine Cervical Neoplasms (2) · Aging, Premature (1)
Blood-Borne Infections (60) · Communicable Diseases (60) · Genital Diseases (60) · Immune System Diseases (60) · Immunologic Deficiency Syndromes (60) · Lentivirus Infections (60) · RNA Virus Infections (60) · Retroviridae Infections (60) · Sexually Transmitted Diseases, Viral (60) · Slow Virus Diseases (60) · Urogenital Diseases (60) · Virus Diseases (60) · Infections (59) · HIV Infections (57) · Sexually Transmitted Diseases (57)
Lamivudine (2) · Referral and Consultation (2) · Seroconversion (2) · Standard of Care (2) · Diet Therapy (1) · Estradiol (1) · Ethanol (1) · HIV Testing (1) · Lenalidomide (1) · Lifting (1) · Motivational Interviewing (1) · N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide (1) · Nutrition Assessment (1) · Olfactory Training (1) · Patient Navigation (1)
Columbia University (8) · Fred Hutchinson Cancer Center (4) · University of California, Berkeley (3) · University of California, San Francisco (3) · First Affiliated Hospital of Zhejiang University (2) · National Institute of Allergy and Infectious Diseases (NIAID) (2) · Okan University (2) · University of California, Los Angeles (2) · University of California, San Diego (2) · Abdelrahman Mahmoud (1) · Albert Einstein College of Medicine (1) · Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria (1) · Barcelona Institute for Global Health (1) · Biogipuzkoa Health Research Institute (1) · Brown University (1)
United States (23) · Tanzania (5) · Kenya (4) · China (3) · Eswatini (3) · Italy (2) · Turkey (Türkiye) (2) · Uganda (2) · Egypt (1) · France (1) · Kyrgyzstan (1) · Mozambique (1) · Netherlands (1) · Puerto Rico (1) · Rwanda (1)
Leeya Pinder, MD, MPH (4) · Margaret M Madeleine, PhD, MPH (4) · Rachel L Winer, PhD, MPH (4) · Jingshen Wang, PhD (2) · Abedalrahman Dosoky (1) · Ahmed Kamel (1) · Alfred Balasa,, Associate Professor (1) · Amon Sabasaba, MD (1) · Angela Bazzi, PhD, MPH (1) · Anneka Hooft, MD, MPH (1) · Averie Gachuhi, MSc (1) · Batya Elul, PhD MD (1) · Batya Elul, PhD, MSc (1) · Casper Rokx, MD PhD (1)
PMID 38196655, PMID 38336793, PMID 16863045, PMID 26189154, PMID 28245099, PMID 29112963, PMID 30428290, PMID 30676359, PMID 30704819, PMID 31259847, PMID 32032303, PMID 32193795, PMID 32538796, PMID 32932412, PMID 33228757, PMID 33710019, PMID 35584814, PMID 36281153, PMID 36406043, PMID 36696639, PMID 36725781, PMID 36932369, PMID 37301833, PMID 38672778, PMID 38718757, PMID 38823393, PMID 39098325, PMID 41044777, PMID 41702639, PMID 42469890, PMID 42814903
U24CA275417 (5), UG1CA275402 (4), R01MH125746 (2), 1RM1DA063351 (1), 5UG1CA284671-03 (1), 5UG1CA284918-03 (1), K76AG064545 (1), R01AA031936 (1), R01AG102277 (1), R01AI100059 (1), R01DA051849 (1), R01DA057886 (1), R01MH089831 (1), R01MH107330 (1), R01MH137280 (1)